Entrepreneurship Seminar Series for Research Translation: Things to Consider: Developing a Manufacturable Therapy

​For researchers developing therapeutic products, early choices about how a product will be manufactured and controlled can make or break its path to the clinic. This session introduces core CMC (Chemistry, Manufacturing, and Controls) concepts behind manufacturability and quality, giving you a practical framework to avoid common pitfalls during therapy development.

​Speaker: Caroline Dugopolski, Senior Principal Consultant (CMC & Quality) at SciLucent

​RKC/CILSE 101